The RhoA dependent anti-metastatic function of RKIP in breast cancer

被引:11
作者
Kalpana, Gardiyawasam [1 ]
Figy, Christopher [1 ]
Feng, Jingwei [1 ,3 ]
Tipton, Claire [1 ]
De Castro, Julius N. [1 ]
Bach, Vu N. [1 ]
Borile, Clariza [1 ]
LaSalla, Alexandria [1 ]
Odeh, Hussain N. [1 ]
Yeung, Miranda [1 ]
Garcia-Mata, Rafael [2 ]
Yeung, Kam C. [1 ]
机构
[1] Univ Toledo, Coll Med & Life Sci, Dept Canc Biol, Hlth Sci Campus, Toledo, OH 43614 USA
[2] Univ Toledo, Coll Nat Sci, Dept Biol Sci, Toledo, OH 43614 USA
[3] Southern Med Univ, Nanfang Hosp, Dept Plast & Cosmet Surg, 1838 Guangzhou North Rd, Guangzhou 510515, Guangdong, Peoples R China
关键词
E-CADHERIN EXPRESSION; ADHERENS JUNCTIONS; PROTEIN SUPPRESSES; KINASE-ACTIVITY; CELL-ADHESION; METASTASIS; INVASION; PATHWAY; PROGRESSION; DOWNSTREAM;
D O I
10.1038/s41598-021-96709-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Raf-1 kinase inhibitor protein was initially discovered as a physiological kinase inhibitor of the MAPK signaling pathway and was later shown to suppress cancer cell invasion and metastasis. Yet, the molecular mechanism through which RKIP executes its effects is not completely defined. RhoA has both a pro- and anti-metastatic cell-context dependent functions. Given that Rho GTPases primarily function on actin cytoskeleton dynamics and cell movement regulation, it is possible that one way RKIP hinders cancer cell invasion/metastasis is by targeting these proteins. Here we show that RKIP inhibits cancer cell invasion and metastasis by stimulating RhoA anti-tumorigenic functions. Mechanistically, RKIP activates RhoA in an Erk2 and GEF-H1 dependent manner to enhance E-cadherin membrane localization and inhibit CCL5 expression.
引用
收藏
页数:14
相关论文
共 41 条
[1]   Raf Kinase Inhibitor Protein RKIP Enhances Signaling by Glycogen Synthase Kinase-3β [J].
Al-Mulla, Fahd ;
Bitar, Milad S. ;
Al-Maghrebi, May ;
Behbehani, Abdulla I. ;
Al-Ali, Waleed ;
Rath, Oliver ;
Doyle, Brendan ;
Tan, Kit Yee ;
Pitt, Andrew ;
Kolch, Walter .
CANCER RESEARCH, 2011, 71 (04) :1334-1343
[2]   WNT signalling pathways as therapeutic targets in cancer [J].
Anastas, Jamie N. ;
Moon, Randall T. .
NATURE REVIEWS CANCER, 2013, 13 (01) :11-26
[3]   Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression [J].
Beshir, Anwar B. ;
Ren, Gang ;
Magpusao, Anniefer N. ;
Barone, Lauren M. ;
Yeung, Kam C. ;
Fenteany, Gabriel .
CANCER LETTERS, 2010, 299 (02) :137-149
[4]   Rho GTPases and their effector proteins [J].
Bishop, AL ;
Hall, A .
BIOCHEMICAL JOURNAL, 2000, 348 (02) :241-255
[5]   The small GTPases rho and rac are required for the establishment of cadherin-dependent cell-cell contacts [J].
Braga, VMM ;
Machesky, LM ;
Hall, A ;
Hotchin, NA .
JOURNAL OF CELL BIOLOGY, 1997, 137 (06) :1421-1431
[6]   Mammalian diaphanous-related formin Dia1 controls the organization of E-cadherin-mediated cell-cell junctions [J].
Carramusa, Letizia ;
Ballestrem, Christoph ;
Zilberman, Yuliya ;
Bershadsky, Alexander D. .
JOURNAL OF CELL SCIENCE, 2007, 120 (21) :3870-3882
[7]   Cell adhesion and signalling by cadherins and Ig-CAMs in cancer [J].
Cavallaro, U ;
Christofori, G .
NATURE REVIEWS CANCER, 2004, 4 (02) :118-132
[8]   The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene [J].
Christofori, G ;
Semb, H .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (02) :73-76
[9]   Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7 [J].
Dangi-Garimella, Surabhi ;
Yun, Jieun ;
Eves, Eva M. ;
Newman, Martin ;
Erkeland, Stefan J. ;
Hammond, Scott M. ;
Minn, Andy J. ;
Rosner, Marsha Rich .
EMBO JOURNAL, 2009, 28 (04) :347-358
[10]   RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration [J].
Datar, Ila ;
Qiu, Xiaoliang ;
Ma, Hong Zhi ;
Yeung, Miranda ;
Aras, Shweta ;
de la Serna, Ivana ;
Al-Mulla, Fahd ;
Thiery, Jean Paul ;
Trumbly, Robert ;
Fan, Xuan ;
Cui, Hongjuan ;
Yeung, Kam C. .
ONCOTARGET, 2015, 6 (36) :39050-39061